These medications mimic GLP-1s effects, reducing hunger and calorie intake, which supports effective and sustained weight loss
Although evidence on sex differences in semaglutides weight loss efficacy remains controversial, several hypotheses have been proposed to explain why females may experience greater weight reduction than males: 1) Pharmacokinetic differences: females often exhibit higher plasma levels of GLP-1 RAs due to lower BW and slower drug clearance compared with males, resulting in increased exposure to the medication and potentially greater weight loss [55,56,57]
Both generate feelings of nervousness and unease
Losing too much muscle and lean mass during weight loss can make it more challenging to maintain weight loss in the long term and increase the risk of muscle and bone-related health conditions in the future
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month, multicenter, randomized, controlled trial (ALADIN III Study)
Scientists examined Danish health registries covering 480,231 women, representing a total of 756,636 pregnancies
:max_bytes(150000):strip_icc()/VWH-GettyImages-2190414326-0d878e64bbf84b179058fbdc220cf21e.jpg)
